# Effect of Higher Doses of Remifentanil on Postoperative Pain in Patients Undergoing Thyroidectomy

> **NCT01761149** · PHASE4 · UNKNOWN · sponsor: **Central South University** · enrollment: 60 (estimated)

## Conditions studied

- Nodular Goiter

## Interventions

- **DRUG:** Remifentanil

## Key facts

- **NCT ID:** NCT01761149
- **Lead sponsor:** Central South University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-12
- **Primary completion:** 2013-03
- **Final completion:** —
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2013-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01761149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01761149, "Effect of Higher Doses of Remifentanil on Postoperative Pain in Patients Undergoing Thyroidectomy". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01761149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*